magnesium sulfate has been researched along with Atrial Fibrillation in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.47) | 18.7374 |
1990's | 18 (26.47) | 18.2507 |
2000's | 32 (47.06) | 29.6817 |
2010's | 13 (19.12) | 24.3611 |
2020's | 4 (5.88) | 2.80 |
Authors | Studies |
---|---|
Atwater, M; Hodgson, R; Hoffer, M; Pourmand, A; Tran, QK | 1 |
Jessop, K | 1 |
Bellomo, R; Bitker, L; Cioccari, L; Cutuli, SL; Eastwood, GM; Fukushima, JT; Hajjar, LA; Hessels, L; Matalanis, G; Osawa, EA; Peck, L; Seevanayagam, S; Yanase, F; Young, H | 1 |
Baccouche, R; Boubaker, R; Khattech, I; Majed, K; Mhadhbi, H; Zaouche, K | 1 |
Cheewinmethasiri, J; Chittawatanarat, K; Ko-iam, W; Nawarawong, W; Sudthiviseschai, P; Taksaudom, N | 1 |
Azaiez, N; Belguith, A; Beltaief, K; Ben Soltane, H; Boubaker, H; Bouida, W; Boukef, R; Dridi, Z; Grissa, MH; Methemem, M; Msolli, MA; Nouira, S; Sekma, A; Trabelsi, I | 1 |
Bond, C; Heitz, C; Milne, WK; Morgenstern, J | 1 |
Adams, N | 1 |
Bänsch, D; Dreißiger, K; Kohlschein, P; Schuff-Werner, P | 1 |
Aissaoui, N; Alazard, M; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Le-Heuzey, JY; Salem, JE; Urien, S | 1 |
Aarabi, M; Emami Zeydi, A; Ghafari, R; Gholipour Baradari, A; Jafari, M | 1 |
Charnigo, R; Darrat, Y; Delisle, B; Di Biase, L; Elayi, CS; Metawee, M; Morales, G; Natale, A; Sorrell, V | 1 |
Frampton, GK; Jones, J; Price, A; Shepherd, J; Tanajewski, L; Turner, D | 1 |
Clyne, CA; Henyan, N; Kluger, J; Migeed, M; Shah, SA; Silver, BB; White, CM; Yarlagadda, R | 1 |
Hofmann, R; Hönig, S; Kammler, J; Kypta, A; Leisch, F; Schmitt, B; Steinwender, C | 1 |
Brown, A; Chu, K; Emerson, G; Evans, R; Greenslade, J | 1 |
Chawla, D; Coleman, CI; Ghatak, A; Kluger, J; Sood, N; Talati, R | 1 |
Vos, MA | 1 |
Bernstein, V; Cook, RC; Gin, K; Humphries, KH; Janusz, MT; Lee, MK; Slavik, RS; Tholin, M | 1 |
Benetis, R; Raliene, L; Simatoniene, V; Sirvinskas, E; Svagzdiene, M | 1 |
Antonatos, D; Babalis, D; Christou, A; Kafkas, N; Katsanos, S; Nikolaou, N; Patsilinakos, S; Spanodimos, S | 1 |
Baker, WL; Reinhart, K; Siv, ML | 1 |
Agostini, M; Angelini, GD; Caputo, M; Fino, C; Grossi, C; Reeves, BC; Santo, KC; Suleiman, MS | 1 |
Abdel Azeem, MS; Al-Agaty, AE; Ali, WG; Khalil, MA | 1 |
Alhan, C; Dagdelen, S; Karabulut, H; Toraman, F | 1 |
Chiariello, L; de Notaris, S; De Paulis, R; Forlani, S; Ghini, AS; Nardi, P; Proietti, I; Tomai, F | 1 |
Demirtas, MM; Icer, UA; Kaplan, M; Kut, MS | 1 |
Caron, MF; Kalus, JS; Kluger, J; Ritvo, A; Tsikouris, JP; White, CM | 1 |
Amano, A; Doi, S; Fujisaki, H; Hayashi, I; Ishikawa, N; Miyakawa, H; Takazawa, K | 1 |
Chung, JO; Kalus, JS; Kenyon, KW; Kluger, J; Spencer, AP; Tsikouris, JP; White, CM; Ziska, M | 1 |
Boley, TM; Cetindag, IB; Hazelrigg, SR; Moulton, KP; Polancic, JE; Quin, JA; Shawgo, TS; Trammell, GL; Verhulst, S | 1 |
Kasegawa, H; Kohno, H; Koyanagi, T; Miyazaki, M | 1 |
Brackbill, ML; Moberg, L | 1 |
Davey, MJ; Teubner, D | 1 |
Connolly, SJ; Crystal, E; Garfinkle, M; Lashevsky, I; Lau, C; Miller, S | 1 |
Coleman, CI; Gillespie, EL; Henyan, NN; Kluger, J; White, CM | 1 |
Aerra, V; Fabri, BM; Grayson, AD; Kuduvalli, M; Moloto, AN; Oo, AY; Srinivasan, AK | 1 |
Bil'dinov, OA; Bregvadze, IN; Chazov, EI; Golitsyn, SP; Klimenko, IuL; Kratskina, TL; Maĭkov, EB; Rozenshtraukh, LV; Smirnova, MIu; Sokolov, SF | 1 |
Akbulut, B; Reşatoğlu, AG; Uymaz, OK; Yener, A | 1 |
Coleman, CI; Kluger, J; Tercius, AJ; White, CM | 1 |
Atiq, F; Hamid, M; Kamal, RS; Khan, FH; Naqvi, HI; Sami, SA; Shafquat, A | 1 |
Hanhela, R; Karlqvist, KE; Koistinen, J; Laurila, J; Lepojärvi, MV; Nissinen, J; Pokela, R; Ruokonen, A; Salmela, E; Wistbacka, JO | 1 |
Gilman, JK; Hays, JV; Rubal, BJ | 1 |
DeWeese, G; Merrill, JJ; Wharton, JM | 1 |
Brocki, Z; Kaczmarek, J; Ponizyński, A; Szyszka, A; Wachowiak-Baszyńska, H | 1 |
Oettinger, M; Perlitz, Y | 1 |
Ilton, M; Thompson, PL | 1 |
Järvinen, A; Nieminen, MS; Parikka, H; Pellinen, T; Toivonen, L; Verkkala, K | 1 |
Deshmukh, PK; Joshi, PP; Salkar, RG | 1 |
Chiavacci, P; Dal Corso, B; Dalla Volta, S; Furlan, G; Luzzani, A; Terzi, A | 1 |
Curwin, JH; Sachs, RG; Winters, SL | 1 |
Cotter, L; Fitchet, A; Hobbs, WJ | 1 |
Eckel, L; Grossmann, H; Wollert, HG | 1 |
Alstrup, P; Jensen, BM; Klitgård, NA | 1 |
Carlson, J; Ingemansson, MP; Olsson, SB | 1 |
Bellamy, MC; Koelzow, H | 1 |
Berger, AK; Hannan, RL; Katz, NM; Solomon, AJ; Trivedi, KK | 1 |
Arnold, DJ | 1 |
Adamec, R; Perneger, TV; Romand, JA; Suter, PM; Treggiari-Venzi, MM; Waeber, JL | 1 |
Ingemansson, MP; Olsson, SB; Smideberg, B | 1 |
Chiladakis, JA; Davlouros, P; Manolis, AS; Stathopoulos, C | 1 |
Alhan, HC; Dagdelen, S; Karabulut, EH; Tarcan, S; Toraman, F | 1 |
Akça, S; Cete, Y; Eray, E; Eray, O; Oktay, C; Pekdemir, M | 1 |
Carlson, J; Ingemansson, MP; Olsson, SB; Platonov, P | 1 |
Arstall, MA; Hii, JT; Horowitz, JD; Lehman, RG | 1 |
Alford, WC; Fanning, WJ; Roach, A; Stoney, WS; Thomas, CS; Tomichek, R | 1 |
Shao, M | 1 |
Afonso, JS; Carvalho, E; Fernandes, JS; Pereira, D; Pereira, JN; Rabaçal, C | 1 |
9 review(s) available for magnesium sulfate and Atrial Fibrillation
Article | Year |
---|---|
Utility of magnesium sulfate in the treatment of rapid atrial fibrillation in the emergency department: a systematic review and meta-analysis.
Topics: Atrial Fibrillation; Emergency Service, Hospital; Heart Rate; Humans; Magnesium; Magnesium Sulfate | 2022 |
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cost-Benefit Analysis; Databases, Factual; Humans; Infusions, Intravenous; Magnesium Sulfate; Randomized Controlled Trials as Topic; Sotalol | 2008 |
Beyond the guidelines: new and novel agents for the prevention of atrial fibrillation after cardiothoracic surgery.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Coronary Artery Bypass; Drug Therapy, Combination; Fatty Acids, Unsaturated; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnesium Sulfate; Postoperative Complications; Practice Guidelines as Topic; Thoracic Surgical Procedures | 2011 |
Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Coronary Artery Bypass; Drug Administration Schedule; Drug Evaluation; Female; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Prospective Studies; Research Design; Retrospective Studies; Stroke Volume; Treatment Outcome | 2005 |
Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Length of Stay; Magnesium Sulfate; Postoperative Complications; Randomized Controlled Trials as Topic; Thoracic Surgical Procedures | 2005 |
Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis.
Topics: Atrial Fibrillation; Humans; Injections, Intravenous; Length of Stay; Magnesium Sulfate | 2005 |
Cardiology.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiology; Cerebrovascular Disorders; Heart Diseases; Humans; Magnesium Sulfate; Myocardial Reperfusion | 1994 |
Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Humans; Infusions, Intravenous; Injections, Intravenous; Magnesium Sulfate; Male; Recurrence; Syncope; Tachycardia, Ventricular | 1997 |
Intravenous magnesium for the treatment of cardiac arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Humans; Magnesium Sulfate; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ventricular | 2000 |
35 trial(s) available for magnesium sulfate and Atrial Fibrillation
Article | Year |
---|---|
Continuous Magnesium Infusion to Prevent Atrial Fibrillation After Cardiac Surgery: A Sequential Matched Case-Controlled Pilot Study.
Topics: Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Magnesium; Magnesium Sulfate; Pilot Projects | 2020 |
Magnesium Sulfate: an adjunctive therapy in the first hour of management of rapid atrial fibrillation in the emergency department.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Service, Hospital; Humans; Magnesium Sulfate; Prospective Studies | 2021 |
Magnesium Sulfate Reduces Incidence of Atrial Fibrillation after Coronary Arterial Bypass Surgery: What Is the Proper Dose? A Randomized Trial.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Electrocardiography; Humans; Incidence; Magnesium Sulfate | 2016 |
Low-dose Magnesium Sulfate Versus High Dose in the Early Management of Rapid Atrial Fibrillation: Randomized Controlled Double-blind Study (LOMAGHI Study).
Topics: Administration, Intravenous; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Magnesium Sulfate; Male; Middle Aged | 2019 |
A double-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Calcium; Cardioplegic Solutions; Cardiopulmonary Bypass; Coronary Artery Bypass; Dose-Response Relationship, Drug; Double-Blind Method; Elective Surgical Procedures; Electrocardiography; Female; Humans; Iran; Magnesium Sulfate; Male; Middle Aged; Potassium; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Impact of magnesium sulfate on serum magnesium concentrations and intracellular electrolyte concentrations among patients undergoing radio frequency catheter ablation.
Topics: Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female; Humans; Infusions, Intravenous; Magnesium; Magnesium Sulfate; Male; Middle Aged; Mouth Mucosa; Postoperative Complications; Time Factors | 2008 |
Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Synergism; Electrocardiography; Female; Heart Conduction System; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Placebo Effect; Prospective Studies; Sulfonamides; Treatment Outcome | 2010 |
Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Emergency Service, Hospital; Female; Heart Rate; Hospitals, University; Humans; Linear Models; Magnesium Sulfate; Male; Middle Aged; Placebos; Queensland; Sodium Chloride; Time Factors; Young Adult | 2009 |
Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Female; Heart Valves; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Prospective Studies | 2009 |
Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Torsades de Pointes; Treatment Outcome | 2010 |
Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial.
Topics: Aged; Atrial Fibrillation; Biomarkers; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Heart Arrest, Induced; Humans; Intraoperative Care; Magnesium Sulfate; Male; Middle Aged; Treatment Outcome | 2011 |
The value of P dispersion on predicting atrial fibrillation after coronary artery bypass surgery: effect of magnesium on P dispersion.
Topics: Age Distribution; Aged; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Coronary Stenosis; Electrocardiography; Female; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Postoperative Period; Preoperative Care; Probability; Prospective Studies; Reference Values; Risk Factors; Sensitivity and Specificity; Sex Distribution | 2002 |
Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Sotalol; Treatment Outcome | 2002 |
Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug Monitoring; Female; Heart Rate; Humans; Incidence; Infusions, Intravenous; Length of Stay; Magnesium Sulfate; Male; Middle Aged; Morbidity; Potassium; Premedication; Prospective Studies; Time Factors; Treatment Outcome | 2003 |
Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Sulfonamides | 2003 |
The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting.
Topics: Atrial Fibrillation; Calcium; Coronary Artery Bypass; Female; Heart Atria; Humans; Injections, Intravenous; Magnesium; Magnesium Sulfate; Male; Middle Aged; Pilot Projects; Postoperative Complications | 2004 |
A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Double-Blind Method; Drug Therapy, Combination; Emergency Service, Hospital; Female; Heart Rate; Heart Ventricles; Humans; Magnesium Sulfate; Male; Middle Aged | 2005 |
Supplementation of magnesium to warm blood hyperkalemic cardioplegia for the prevention of atrial fibrillation after coronary artery bypass grafting.
Topics: Atrial Fibrillation; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Artery Disease; Heart Arrest, Induced; Humans; Magnesium Sulfate; Postoperative Complications; Treatment Outcome | 2007 |
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Electrocardiography; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2007 |
Effect of single dose magnesium on arrhythmias in patients undergoing coronary artery bypass surgery.
Topics: Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Humans; Incidence; Magnesium Sulfate; Male; Middle Aged; Perioperative Care; Tachycardia, Supraventricular; Tachycardia, Ventricular | 2008 |
Magnesium substitution in elective coronary artery surgery: a double-blind clinical study.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Calcium; Cardiac Complexes, Premature; Coronary Artery Bypass; Creatine Kinase; Double-Blind Method; Elective Surgical Procedures; Female; Humans; Infusions, Intravenous; Isoenzymes; Magnesium; Magnesium Chloride; Magnesium Sulfate; Male; Middle Aged; Pacemaker, Artificial; Prospective Studies; Tachycardia, Supraventricular; Ventricular Fibrillation | 1995 |
Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Digoxin; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Heart Ventricles; Humans; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1994 |
[Magnesium protects myocardium during electric cardioversion but does not increase effectiveness].
Topics: Adult; Aged; Atrial Fibrillation; Electric Countershock; Heart; Humans; Magnesium Sulfate; Middle Aged; Postoperative Complications; Premedication; Treatment Outcome | 1993 |
The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation.
Topics: Aged; Analysis of Variance; Atrial Fibrillation; Coronary Artery Bypass; Female; Heart Rate; Humans; Infusions, Intravenous; Magnesium; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Treatment Outcome | 1993 |
Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Tachycardia, Supraventricular; Verapamil | 1995 |
Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate.
Topics: Aged; Atrial Fibrillation; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Middle Aged; Postoperative Complications; Prospective Studies; Thoracic Surgery | 1996 |
Magnesium sulfate prevents atrial tachyarrhythmias after cardiac and non-cardiac surgery--what is the common mechanism?
Topics: Atrial Fibrillation; Cardiac Surgical Procedures; Heart Rate; Humans; Infusions, Intravenous; Magnesium Sulfate; Prospective Studies; Thoracic Surgical Procedures; Treatment Outcome | 1997 |
Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting.
Topics: Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Humans; Incidence; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Time Factors; Water-Electrolyte Imbalance | 1997 |
The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension; Incidence; Infusions, Intravenous; Intraoperative Care; Length of Stay; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Propranolol; Prospective Studies; Single-Blind Method | 2000 |
Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbon Dioxide; Coronary Artery Bypass; Double-Blind Method; Female; Hemodynamics; Humans; Magnesium Sulfate; Male; Middle Aged; Oxygen; Partial Pressure; Postoperative Complications | 2000 |
Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardioplegic Solutions; Chronic Disease; Drug Therapy, Combination; Electrocardiography; Female; Glucose; Humans; Infusions, Intravenous; Insulin; Magnesium Sulfate; Male; Middle Aged; Potassium; Time Factors | 2000 |
Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Tachycardia, Paroxysmal | 2001 |
Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Length of Stay; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Premedication | 2001 |
Effects of MgSO4 and glucose, insulin and potassium (GIK) on atrial conduction during the first 12 hours after DC-conversion of chronic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Chronic Disease; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Glucose; Heart Conduction System; Humans; Infusions, Intravenous; Insulin; Magnesium Sulfate; Male; Middle Aged; Potassium; Time Factors; Treatment Outcome | 2001 |
Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting.
Topics: Adult; Aged; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Magnesium; Magnesium Sulfate; Male; Middle Aged; Prospective Studies; Tachycardia, Supraventricular | 1991 |
24 other study(ies) available for magnesium sulfate and Atrial Fibrillation
Article | Year |
---|---|
Intravenous magnesium sulfate inducing acute respiratory failure in a patient with myasthenia gravis.
Topics: Atrial Fibrillation; Female; Humans; Magnesium; Magnesium Sulfate; Myasthenia Gravis; Respiratory Distress Syndrome; Respiratory Insufficiency | 2022 |
Hot Off the Press: Low-dose Magnesium Sulfate Versus High Dose in the Early Management of Rapid Atrial Fibrillation: Randomized Controlled Double-blind Study.
Topics: Atrial Fibrillation; Double-Blind Method; Heart Rate; Humans; Magnesium Sulfate | 2019 |
Magnesium for atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Humans; Magnesium; Magnesium Sulfate | 2019 |
Exclusion of thrombocytopenia as a contraindication for invasive radiofrequency ablation in a patient with paroxysmal atrial fibrillation by using magnesium anticoagulation instead of EDTA: another case of anticoagulant-induced pseudo-thrombocytopenia.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Contraindications; Edetic Acid; Female; Humans; Magnesium Sulfate; Platelet Aggregation; Platelet Count; Recurrence; Thrombocytopenia | 2015 |
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Critical Illness; Dobutamine; Drug Design; Female; Heart Rate; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sympathomimetics; Tachycardia | 2016 |
Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Digoxin; Double-Blind Method; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Proportional Hazards Models; ST Elevation Myocardial Infarction | 2016 |
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome | 2009 |
Enhanced efficacy with MgSO4 due to an additive, alternative, or dual mode of action?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Drug Synergism; Drug Therapy, Combination; Humans; Magnesium Sulfate; Treatment Outcome | 2009 |
Atrial fibrillation and changes in serum and urinary electrolyte levels after coronary artery bypass grafting surgery.
Topics: Aged; Atrial Fibrillation; Body Mass Index; Calcium; Chlorides; Coronary Artery Bypass; Data Interpretation, Statistical; Electrocardiography; Electrolytes; Heart Rate; Humans; Informed Consent; Magnesium; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Preoperative Period; Reference Values; Statistics, Nonparametric; Stroke Volume; Time Factors | 2009 |
A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Humans; Infusions, Intravenous; Intraoperative Complications; Lung; Magnesium Sulfate; Male; Middle Aged; Perioperative Care; Postoperative Care; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Telemetry | 2013 |
[Procedure and problem for short-term outcomes on off-pump coronary artery bypass grafting].
Topics: Antibiotic Prophylaxis; Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Humans; Length of Stay; Magnesium Sulfate; Mammary Arteries; Omentum; Perioperative Care; Postoperative Complications; Retrospective Studies; Risk; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2003 |
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chemoprevention; Cohort Studies; Drug Synergism; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Outcome | 2003 |
Magnesium sulfate for prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Injections, Intravenous; Length of Stay; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies | 2005 |
Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemoprevention; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Incidence; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Probability; Retrospective Studies; Sotalol; Treatment Outcome | 2006 |
[The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Benzamides; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Time Factors; Torsades de Pointes; Treatment Outcome | 2007 |
Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Topics: Aged; Atrial Fibrillation; Digoxin; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Magnesium Sulfate; Male; Middle Aged; Wolff-Parkinson-White Syndrome | 1994 |
Asymptomatic paroxysmal atrial fibrillation during intravenous magnesium sulfate treatment in preeclampsia.
Topics: Adult; Atrial Fibrillation; Female; Humans; Magnesium Sulfate; Pre-Eclampsia; Pregnancy | 1993 |
Atrial arrhythmias after cardiac surgery.
Topics: Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Magnesium Sulfate; Postoperative Complications | 1997 |
Modification of intrinsic AV-nodal properties by magnesium in combination with glucose, insulin, and potassium (GIK) during chronic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardioplegic Solutions; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Glucose; Humans; Infusions, Intravenous; Insulin; Magnesium Sulfate; Male; Middle Aged; Potassium | 1998 |
Magnesium and atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Magnesium Sulfate | 1998 |
Magnesium efficacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Male; Middle Aged; Tachycardia, Ventricular; Time Factors; Treatment Outcome | 2000 |
Sotalol-induced torsade de pointes: management with magnesium infusion.
Topics: Aged; Amiodarone; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Humans; Magnesium Sulfate; Recurrence; Sotalol; Torsades de Pointes | 1992 |
[Clinical effects of magnesium sulfate in the treatment of supraventricular tachyarrhythmia].
Topics: Adult; Aged; Atrial Fibrillation; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1990 |
[Therapeutic effectiveness of intravenous magnesium sulfate in tachyarrhythmia. Apropos of 4 clinical cases].
Topics: Adult; Atrial Fibrillation; Drug Administration Schedule; Drug Evaluation; Electrocardiography; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Tachycardia | 1989 |